Advertisement
Bausch + Lomb Corporation

Bausch + Lomb Corporation Fundamental Analysis

BLCONYSE
HealthcareMedical - Instruments & Supplies
$15.11
$0.07(0.46%)
U.S. Market is Open · 15:23
Advertisement

Bausch + Lomb Corporation Fundamental Analysis

Bausch + Lomb Corporation (BLCO) shows weak financial fundamentals with a PE ratio of -24.75, profit margin of -4.21%, and ROE of -3.41%. The company generates $5.2B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.93
Current Ratio1.53

Areas of Concern

ROE-3.41%
Operating Margin5.91%
Cash Position4.82%
We analyze BLCO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 26.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
26.3/100

We analyze BLCO's fundamental strength across five key dimensions:

Efficiency Score

Weak

BLCO struggles to generate sufficient returns from assets.

ROA > 10%
-1.59%

Valuation Score

Excellent

BLCO trades at attractive valuation levels.

PE < 25
-24.75
PEG Ratio < 2
-0.93

Growth Score

Weak

BLCO faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

BLCO maintains a strong and stable balance sheet.

Debt/Equity < 1
0.01
Current Ratio > 1
1.53

Profitability Score

Weak

BLCO struggles to sustain strong margins.

ROE > 15%
-340.91%
Net Margin ≥ 15%
-4.21%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is BLCO Expensive or Cheap?

P/E Ratio

BLCO trades at -24.75 times earnings. This suggests potential undervaluation.

-24.75

PEG Ratio

When adjusting for growth, BLCO's PEG of -0.93 indicates potential undervaluation.

-0.93

Price to Book

The market values Bausch + Lomb Corporation at 0.85 times its book value. This may indicate undervaluation.

0.85

EV/EBITDA

Enterprise value stands at 7.83 times EBITDA. This is generally considered low.

7.83

How Well Does BLCO Make Money?

Net Profit Margin

For every $100 in sales, Bausch + Lomb Corporation keeps $-4.21 as profit after all expenses.

-4.21%

Operating Margin

Core operations generate 5.91 in profit for every $100 in revenue, before interest and taxes.

5.91%

ROE

Management delivers $-3.41 in profit for every $100 of shareholder equity.

-3.41%

ROA

Bausch + Lomb Corporation generates $-1.59 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.59%

Following the Money - Real Cash Generation

Operating Cash Flow

Bausch + Lomb Corporation generates limited operating cash flow of $341.67M, signaling weaker underlying cash strength.

$341.67M

Free Cash Flow

Bausch + Lomb Corporation generates weak or negative free cash flow of $4.35M, restricting financial flexibility.

$4.35M

FCF Per Share

Each share generates $0.01 in free cash annually.

$0.01

FCF Yield

BLCO converts 0.08% of its market value into free cash.

0.08%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-24.75

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.93

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.85

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.04

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.006

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.53

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.03

vs 25 benchmark

ROA

Return on assets percentage

-0.02

vs 25 benchmark

ROCE

Return on capital employed

0.03

vs 25 benchmark

How BLCO Stacks Against Its Sector Peers

MetricBLCO ValueSector AveragePerformance
P/E Ratio-24.7534.27 Better (Cheaper)
ROE-3.41%377.00% Weak
Net Margin-4.21%-42945.00% (disorted) Weak
Debt/Equity0.010.78 Strong (Low Leverage)
Current Ratio1.535.54 Neutral
ROA-1.59%-162.00% (disorted) Weak

BLCO outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Bausch + Lomb Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ